
Clarivate Sheds Life Sciences Division in $600 Million Deal
Clarivate is offloading its Life Sciences & Healthcare segment to investment firm Altaris for $600 million, a move aimed at streamlining the company’s portfolio. The transaction, expected to close by the end of the year, marks a pivot toward prioritizing subscription-based intelligence solutions in the academic and intellectual property sectors.




,regionOfInterest=(1765,1222)&hash=b9d7c6e634ef7530e7b4c080a07cf34f5a0406d6a4dff6abacb554a75f0d29c6)